Search Results

Filter
  • 1-10 of  606 results for ""CANCER vaccines""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A novel costimulatory molecule gene-modified leukemia cell-derived exosome enhances the anti-leukemia efficacy of DC vaccine in mouse models.

  • Authors : Zhang D; Department of Hematology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Jiang Y

Subjects: Dendritic Cells*/Dendritic Cells*/Dendritic Cells*/immunology ; Exosomes*/Exosomes*/Exosomes*/immunology ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/immunology

  • Source: Vaccine [Vaccine] 2024 Oct 24; Vol. 42 (24), pp. 126097. Date of Electronic Publication: 2024 Jul 02.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

In silico designed mRNA vaccines targeting CA-125 neoantigen in breast and ovarian cancer.

  • Authors : Lu L; Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT 06510, USA; Yale Cancer Center, Yale University, New Haven, CT 06510, USA. Electronic address: .

Subjects: Cancer Vaccines* ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/therapy ; mRNA Vaccines*

  • Source: Vaccine [Vaccine] 2023 Mar 17; Vol. 41 (12), pp. 2073-2083. Date of Electronic Publication: 2023 Feb 20.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Antitumor efficacy of MUC1-derived variable epitope library treatments in a mouse model of breast cancer.

  • Authors : Odales J; Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), AP 70228, Ciudad Universitaria, México DF 04510, MÉXICO.; Servín-Blanco R

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/genetics ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/therapy ; Cancer Vaccines*

  • Source: Vaccine [Vaccine] 2022 Aug 05; Vol. 40 (33), pp. 4796-4805. Date of Electronic Publication: 2022 Jul 01.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Tumor lysate-loaded Bacterial Ghosts as a tool for optimized production of therapeutic dendritic cell-based cancer vaccines.

Subjects: Adjuvants, Immunologic*; Antigens, Neoplasm/Antigens, Neoplasm/Antigens, Neoplasm/*immunology ; Bacterial Vaccines/Bacterial Vaccines/Bacterial Vaccines/*immunology

  • Source: Vaccine [Vaccine] 2018 Jul 05; Vol. 36 (29), pp. 4171-4180. Date of Electronic Publication: 2018 Jun 09.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Bacteria biohybrid oral vaccines for colorectal cancer treatment reduce tumor growth and increase immune infiltration.

  • Authors : Naciute M; School of Pharmacy, University of Otago, Dunedin 9016, New Zealand.; Kiwitt T

Subjects: Cancer Vaccines* ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/therapy; Adjuvants, Immunologic

  • Source: Vaccine [Vaccine] 2021 Sep 15; Vol. 39 (39), pp. 5589-5599. Date of Electronic Publication: 2021 Aug 18.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Personalized cancer vaccines: Targeting the cancer mutanome.

  • Authors : Zhang X; Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, United States.; Sharma PK

Subjects: Molecular Targeted Therapy* ; Mutation*; Antigens, Neoplasm/Antigens, Neoplasm/Antigens, Neoplasm/*immunology

  • Source: Vaccine [Vaccine] 2017 Feb 15; Vol. 35 (7), pp. 1094-1100. Date of Electronic Publication: 2016 Jul 20.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Vaccination with dendritic cells pulsed ex vivo with gp100 peptide-decorated liposomes enhances the efficacy of anti PD-1 therapy in a mouse model of melanoma.

  • Authors : Yazdani M; Department of Applied Cell Sciences, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

Subjects: Cancer Vaccines* ; Melanoma*/Melanoma*/Melanoma*/therapy; Animals

  • Source: Vaccine [Vaccine] 2020 Jul 31; Vol. 38 (35), pp. 5665-5677. Date of Electronic Publication: 2020 Jul 09.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth.

  • Authors : Bryson PD; Mork Family Department of Chemical Engineering and Materials Science, Viterbi School of Engineering, University of Southern California, Los Angeles, CA 90089, USA.; Han X

Subjects: Cancer Vaccines/Cancer Vaccines/Cancer Vaccines/*immunology ; Dendritic Cells/Dendritic Cells/Dendritic Cells/*immunology ; Genetic Vectors/Genetic Vectors/Genetic Vectors/*immunology

  • Source: Vaccine [Vaccine] 2017 Oct 13; Vol. 35 (43), pp. 5842-5849. Date of Electronic Publication: 2017 Sep 12.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Harnessing T-cell activity against prostate cancer: A therapeutic microparticulate oral cancer vaccine.

  • Authors : Parenky AC; Mercer University, Vaccine Nanotechnology Laboratory, Center for Drug Delivery Research, Atlanta, GA 30341, USA. Electronic address: .; Akalkotkar A

Subjects: Cancer Vaccines/Cancer Vaccines/Cancer Vaccines/*immunology ; Cell-Derived Microparticles/Cell-Derived Microparticles/Cell-Derived Microparticles/*immunology ; Immunotherapy/Immunotherapy/Immunotherapy/*methods

  • Source: Vaccine [Vaccine] 2019 Sep 24; Vol. 37 (41), pp. 6085-6092. Date of Electronic Publication: 2019 Aug 30.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets.

  • Authors : Stanton SE; Cancer Vaccine Institute, University of Washington, Seattle WA, 98109, USA. Electronic address: .; Gad E

Subjects: Antigens, Neoplasm/Antigens, Neoplasm/Antigens, Neoplasm/*analysis ; Antigens, Neoplasm/Antigens, Neoplasm/Antigens, Neoplasm/*immunology ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*pathology

  • Source: Vaccine [Vaccine] 2019 Jun 12; Vol. 37 (27), pp. 3552-3561. Date of Electronic Publication: 2019 May 21.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  606 results for ""CANCER vaccines""